Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
DEST.L Share News (DEST)
DEST Share
Price
DEST Share
News
DEST Share
Chat
DEST Share
Trades
DEST
Live RNS
DEST Share
Charts
DEST Broker
Ratings
DEST Directors
Deals
DEST Financial
Diary
DEST
Fundamentals
DEST Short
Positions
DEST
Media
DEST Company
Research
DEST Company
Timeline
- There is currently no data for DEST
DEST.L News
Destiny Pharma finalises plans for next study of its lead asset
(Sharecast News) - Biotechnology company Destiny Pharma has finalised plans for phase-three studies of its late-stage clinical asset 'XF-73 Nasal', it...
Destiny Pharma starts new drug study for its skin infection treatment
(Alliance News) - Destiny Pharma PLC on Tuesday said it had started a safety study to enable its XF-73 treatment to be labelled as an Investigational ...
Destiny Pharma starts new safety study of dermal formulation
(Sharecast News) - Biotechnology developer Destiny Pharma announced the start of an investigational new drug (IND)-enabling safety study with its nove...
Destiny Pharma loss widens, pins hope on late stage clinical assets
(Alliance News) - Destiny Pharma PLC on Thursday reported a widened interim loss, as it progresses two key clinical assets.
Destiny Pharma gets positive EMA feedback for gut bacteria treatment
(Alliance News) - Destiny Pharma PLC on Wednesday announced that it had received positive feedback from the European Medicine Agency on its NTCD-M3 ph...
Destiny Pharma receives 'positive feedback' from EMA on NTCD-M3
(Sharecast News) - Clinical stage biotechnology company Destiny Pharma has received "positive feedback" from the European Medicine Agency regarding th...
TRADING UPDATES: De La Rue cancels contract; Apollon buys in Jamaica
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
Follow the stocks
